ProfileGDS4132 / 222602_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 32% 19% 26% 24% 30% 23% 30% 44% 44% 32% 41% 33% 41% 37% 34% 40% 46% 45% 42% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10178.937332
GSM201543Muscle PCOS pioglitazone 12135.272719
GSM201544Muscle PCOS pioglitazone 16164.978526
GSM201545Muscle PCOS pioglitazone 20161.778524
GSM201829Muscle PCOS pioglitazone 23178.601830
GSM201830Muscle PCOS pioglitazon 25154.448823
GSM201831Muscle PCOS pioglitazone 27171.035530
GSM201832Muscle PCOS pioglitazone 31112.50344
GSM201833Muscle PCOS pioglitazone 41107.68644
GSM201834Muscle PCOS pioglitazone 8178.271632
GSM201835Muscle PCOS after pioglitazone 10293.077541
GSM201836Muscle PCOS after pioglitazone 12271.292533
GSM201837Muscle PCOS after pioglitazone 16289.296641
GSM201838Muscle PCOS after pioglitazone 20285.220837
GSM201839Muscle PCOS after pioglitazone 23278.844734
GSM201840Muscle PCOS after pioglitazone 25298.707540
GSM201841Muscle PCOS after pioglitazone 272105.5746
GSM201842Muscle PCOS after pioglitazone 3296.971345
GSM201843Muscle PCOS after pioglitazone 42104.53642
GSM201844Muscle PCOS after pioglitazone 82104.85642